原著論文

1. Aoyama M, Yoshioka Y（コレスポンディングオーサー）, Arai Y, Hirai H, Ishimoto R, Nagano K, Higashisaka K, Nagai T, Tsutsumi Y. Intracellular trafficking of particles inside endosomal vesicles is regulated by particle size. J Control Release, 2017 Jun 13;260:183-193.

2. Nishijima N, Hirai T, Misato K, Aoyama M, Kuroda E, Ishii KJ, Higashisaka K, Yoshioka Y（コレスポンディングオーサー）, Tsutsumi Y. Human scavenger receptor A1-mediated inflammatory response to silica particle exposure is size specific. Front Immunol. 2017 Apr 3;8:379.

3. Imai S, Morishita Y, Hata T, Kondoh M, Yagi K, Gao JQ, Nagano K, Higashisaka K, Yoshioka Y（コレスポンディングオーサー）, Tsutsumi Y. Cellular internalization, transcellular transport, and cellular effects of silver nanoparticles in polarized Caco-2 cells following apical or basolateral exposure. Biochem Biophys Res Commun. 2017 Mar 11;484(3):543-549.

4. Handa T, Hirai T, Izumi N, Eto SI, Tsunoda SI, Nagano K, Higashisaka K, Yoshioka Y（コレスポンディングオーサー）, Tsutsumi Y. Identifying a size-specific hazard of silica nanoparticles after intravenous administration and its relationship to the other hazards that have negative correlations with the particle size in mice. Nanotechnology. 2017 Feb 27;28(13):135101.

5. Nagano T, Nagano K, Nabeshi H, Yoshida T, Kamada H, Tsunoda SI, Gao JQ, Higashisaka K, Yoshioka Y, Tsutsumi Y. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes. Biol Pharm Bull. 2017;40(5):726-728.

6. Kuwagata M, Kumagai F, Saito Y, Higashisaka K, Yoshioka Y, Tsutsumi Y. Permeability of skin to silver nanoparticles after epidermal skin barrier disruption in rats. Fundam Toxicol Sci. 2017;4(3):109-19.

7. Isoda K, Daibo T, Yushina K, Yoshioka Y, Tsutsumi Y, Akimoto Y, Kawakami H, Taira Y, Taira I, Yanoshita R, Nishimura T, Ishida I. Hepatotoxicity, nephrotoxicity, and drug/chemical interaction toxicity of platinum nanoparticles in mice. Pharmazie. 2017 Jan 10;72(1):10-16.

総説・ 書籍など

1. Yoshioka Y（コレスポンディングオーサー）, Kuroda E, Hirai T, Tsutsumi Y, Ishii KJ. Allergic responses induced by the immunomodulatory effects of nanomaterials upon skin exposure. Front Immunol. 2017 Feb 16;8:169.

2. Higashisaka K, Nagano K, Yoshioka Y, Tsutsumi Y. Nano-safety Research: Examining the Associations among the Biological Effects of Nanoparticles and Their Physicochemical Properties and Kinetics. Biol Pharm Bull. 2017;40(3):243-248.

招待講演（国内）

1. 吉岡靖雄. 機能性ペプチドによる免疫制御法の開発～感染症ワクチンおよび免疫寛容誘導法の開発～. 日本薬学会第137年会. 2017年3月26日. 宮城

2. Yasuo Yoshioka. Immuno-modulating peptides for vaccine development. 第16回あわじしま感染症・免疫フォーラム. 2017年9月5日-8日.

アウトリーチ

2017年3月、8月：愛知教育大学付属岡崎中学校の生徒に、感染症に対するワクチン開発についてレクチャーしました。